CRCT financial statements and SEC filings
CRCT annual income statement
| Fiscal period end | Revenue | Operating income | Net income | SEC filing |
|---|
| 2025-12-31 | $708.78M | $96.03M | $76.70M | 10-K |
| 2024-12-31 | $712.54M | $76.11M | $62.83M | 10-K |
| 2023-12-31 | $765.15M | $69.98M | $53.64M | 10-K |
| 2022-12-31 | $886.30M | $79.95M | $60.67M | 10-K |
| 2021-12-31 | $1.31B | $192.41M | $140.47M | 10-K |
| 2020-12-31 | $959.03M | $200.51M | $154.58M | 10-K |
CRCT annual balance sheet
| Fiscal period end | Assets | Liabilities | Equity | SEC filing |
|---|
| 2025-12-31 | $580.81M | $237.25M | $343.56M | 10-Q |
| 2024-12-31 | $693.03M | $226.27M | $466.76M | 10-K |
| 2023-12-31 | $750.12M | $215.25M | $534.87M | 10-K |
| 2022-12-31 | $949.63M | $276.89M | $672.74M | 10-K |
| 2021-12-31 | $1.01B | $332.27M | $673.98M | 10-K |
| 2020-12-31 | $581.40M | $352.48M | $228.93M | 10-K |
CRCT annual cash flow
| Fiscal period end | Operating cash flow | Capital expenditure | Financing cash flow | SEC filing |
|---|
| 2025-12-31 | $200.23M | – | -$237.44M | 10-K |
| 2024-12-31 | $264.97M | – | -$156.44M | 10-K |
| 2023-12-31 | $288.10M | – | -$322.19M | 10-K |
| 2022-12-31 | $117.68M | – | -$26.25M | 10-K |
| 2021-12-31 | -$104.95M | – | $260.24M | 10-K |
| 2020-12-31 | $248.23M | – | -$110.92M | 10-K |